Dominik Lipka

Dominik Lipka holds a PhD in biotechnology, specializing in nanobiotechnology and advanced drug delivery systems, with a strong focus on LNP and liposomal formulations. He has extensive experience in the pharmaceutical and biotechnology industry, where he has led the development and implementation of innovative medicinal products and biomedical technologies. His career spans both R&D and leadership roles, combining deep scientific knowledge with strategic oversight. Currently, he serves as Chief Technology Officer and Member of the Management Board at SyVento BioTech, where he directs cutting-edge research in preclinical and clinical drug development.